Meeting Patients with Hepatitis C Where They Are: Lessons from the HIV Epidemic in the USA
Journal of General Internal Medicine·
- DOI
- 10.1007/s11606-026-10629-7
- PMID
- —
- PMCID
- —
- OpenAlex
- W7203643706
- Study type
- Journal article
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The article addresses national HCV eradication goals and advocates for equitable treatment access. It proposes a test-and-treat approach during hospital admission and reframing nonadherence as a need for support rather than a patient deficiency.
Structured evidence summary
Research question
The article examines barriers to hepatitis C virus treatment uptake and proposes applying lessons from HIV care cascade interventions to improve HCV treatment access and equity.
Study design
This is a perspective or commentary article that reviews existing evidence and advocates for policy changes based on HIV care models.
Population and setting
The article focuses on hepatitis C patients in the United States, with particular attention to marginalized populations including people who use drugs.
Main findings
Acute HCV infections have risen in the past decade despite curative direct-acting antivirals. Barriers to HCV treatment include payor restrictions and provider hesitance to treat people who use drugs, despite evidence of high treatment completion in this group. HIV care interventions such as community-based testing, rapid treatment initiation, and federal support for treatment and housing have increased viral suppression rates.
Public-health relevance
The article addresses national HCV eradication goals and advocates for equitable treatment access. It proposes a test-and-treat approach during hospital admission and reframing nonadherence as a need for support rather than a patient deficiency.
Important limitations
This summary is limited to the supplied single-article abstract and metadata. The original paper is required for decision-grade interpretation of the proposed interventions, their evidence base, and applicability across different healthcare settings.
GIDS interpretation
This article was classified under Hepatitis C and Hepatitis E diseases, United States geography, and Treatment topics, making it discoverable in literature surveillance focused on hepatitis care delivery and treatment access in the US context.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.